Skip to content

the efficacy of topical erythropoietin treatment on healing of second degree burned cutaneous burned wounds

the efficacy of topical erythropoietin treatment on healing of second degree burned cutaneous burned wounds

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190810044500N23
Enrollment
48
Registered
2022-03-02
Start date
2022-04-21
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn. Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

Intervention 1: Intervention group: Erythropoietin cream will be made in the Pharmaceutics Laboratory of Yazd School of Pharmacy. Patients with second-degree burns referred to Yazd Martyrs Hospital in

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Presenting to the burn center in the first 24 hours after the burn Having grade II burns, superficial and deep, that involve less than 10% of the body's surface area No comorbidity that delays the repair process (such as diabetes, chronic kidney disease, malignancy, and chronic use of corticosteroids) Absence of respiratory burns as well as chemicals or electric burn No burns on the face and perineum and hand

Exclusion criteria

Exclusion criteria: Concurrent infection during the study Lack of response to treatment The need for skin graft surgery

Design outcomes

Primary

MeasureTime frame
Mean time of wound healing. Timepoint: The wound healing process is measured during the study period on days 1, 3, 7, 10, 14, and 21 after starting to use Erythropoietin cream on the wound area. Method of measurement: Clinical examination.;The rate of pigmentation. Timepoint: The rate of pigmentation is measured during the study period on days 1, 3, 7, 10, 14, and 21 after starting to use Erythropoietin cream in the wound area. Method of measurement: Clinical examination.;The rate of pain. Timepoint: The rate of pain is measured during the study period on days 1, 3, 7, 10, 14, and 21 after starting to use Erythropoietin cream in the wound area. Method of measurement: Clinical examination.;The rate of pruritus. Timepoint: The rate of pruritus is measured during the study period on days 1, 3, 7, 10, 14, and 21 after starting to use Erythropoietin cream in the wound area. Method of measurement: Clinical examination.

Secondary

MeasureTime frame
Complications observed. Timepoint: End of the study. Method of measurement: Based on the doctor's observation and the person's statements.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Saghafi

Yazd University of Medical Sciences

F.saghafi@ssu.ac.ir+98 35 3820 3419

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026